Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Greil

Showing results (61-70 of 145) with videos related to

Pageof 15
Sort By:
International Journal of STD & AIDS|June 18, 2011
Raltegravir in pregnancy: a case series presentationN Taylor, V Touzeau, M Geit, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 19, 2010
Evidence for the conversion of docetaxel into 7'-epidocetaxel in patients receiving Taxotere-based conventional chemotherapyM Czejka, R Greil, E Ulsperger, et al.
Stem Cells (Dayton, Ohio)|May 1, 1996
2',2'-Difluorodeoxycytidine (gemcitabine) induces apoptosis in myeloma cell lines resistant to steroids and 2-chlorodeoxyadenosine (2-CdA)J Gruber, F Geisen, R Sgonc, et al.
Anticancer Research|November 27, 2008
Biweekly oxaliplatin and irinotecan chemotherapy in advanced gastric cancer. A first-line multicenter phase II trial of the Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT)E Wöll, T Kühr, W Eisterer, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 3, 2009
Neoadjuvant bevacizumab, docetaxel and capecitabine combination therapy for HER2/neu-negative invasive breast cancer: Efficacy and safety in a phase II pilot studyR Greil, M Moik, R Reitsamer, et al.
ESMO Open|March 20, 2024
Comment on: Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinomaF Huemer, L Weiss, P Regitnig, et al.
Leukemia|March 1, 1990
Monoclonal antibody B-ly7: a sensitive marker for detection of minimal residual disease in hairy cell leukemiaJ Thaler, O Dietze, V Faber, et al.
Cell Death and Differentiation|October 24, 2000
Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cellsD Bernhard, I Tinhofer, M Tonko, et al.
Clinical and Experimental Immunology|August 1, 1989
Expression of leucocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin lymphomas and leukaemias: possible influence on growth pattern and leukaemic behaviourR Stauder, R Greil, T F Schulz, et al.
American Journal of Clinical Pathology|March 12, 1998
Urticaria pigmentosa: a clinical, hematopathologic, and serologic study of 30 adultsG Topar, C Staudacher, F Geisen, et al.
Pageof 15

Showing results (61-70 of 145) with videos related to

Sort By:
Pageof 15
International Journal of STD & AIDS|June 18, 2011
Raltegravir in pregnancy: a case series presentationN Taylor, V Touzeau, M Geit, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 19, 2010
Evidence for the conversion of docetaxel into 7'-epidocetaxel in patients receiving Taxotere-based conventional chemotherapyM Czejka, R Greil, E Ulsperger, et al.
Stem Cells (Dayton, Ohio)|May 1, 1996
2',2'-Difluorodeoxycytidine (gemcitabine) induces apoptosis in myeloma cell lines resistant to steroids and 2-chlorodeoxyadenosine (2-CdA)J Gruber, F Geisen, R Sgonc, et al.
Anticancer Research|November 27, 2008
Biweekly oxaliplatin and irinotecan chemotherapy in advanced gastric cancer. A first-line multicenter phase II trial of the Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT)E Wöll, T Kühr, W Eisterer, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 3, 2009
Neoadjuvant bevacizumab, docetaxel and capecitabine combination therapy for HER2/neu-negative invasive breast cancer: Efficacy and safety in a phase II pilot studyR Greil, M Moik, R Reitsamer, et al.
ESMO Open|March 20, 2024
Comment on: Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinomaF Huemer, L Weiss, P Regitnig, et al.
Leukemia|March 1, 1990
Monoclonal antibody B-ly7: a sensitive marker for detection of minimal residual disease in hairy cell leukemiaJ Thaler, O Dietze, V Faber, et al.
Cell Death and Differentiation|October 24, 2000
Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cellsD Bernhard, I Tinhofer, M Tonko, et al.
Clinical and Experimental Immunology|August 1, 1989
Expression of leucocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin lymphomas and leukaemias: possible influence on growth pattern and leukaemic behaviourR Stauder, R Greil, T F Schulz, et al.
American Journal of Clinical Pathology|March 12, 1998
Urticaria pigmentosa: a clinical, hematopathologic, and serologic study of 30 adultsG Topar, C Staudacher, F Geisen, et al.
Pageof 15